Postpartum thyroiditis screening: Difference between revisions
Jump to navigation
Jump to search
Sunny Kumar (talk | contribs) |
Sunny Kumar (talk | contribs) |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
*There is insufficient evidence to recommend routine screening for PPT. | |||
There is insufficient evidence to recommend routine screening for | |||
==Screening== | ==Screening== | ||
*There is insufficient evidence to recommend routine screening for PPT | *There is insufficient evidence to recommend routine screening for PPT. | ||
*According to the Endocrinology and Metabolism Clinics of North America<ref name="pmid10874538">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538 }} </ref> screening for postpartum thyroiditis by measuring anti-TPO antibodies should be limited to every high risk pregnant women with: | *According to the Endocrinology and Metabolism Clinics of North America<ref name="pmid10874538">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538 }} </ref> screening for postpartum thyroiditis by measuring anti-TPO antibodies should be limited to every high risk pregnant women with: | ||
**Type 1 DM | **Type 1 DM | ||
Revision as of 00:48, 30 September 2017
|
Postpartum thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Postpartum thyroiditis screening On the Web |
|
American Roentgen Ray Society Images of Postpartum thyroiditis screening |
|
Risk calculators and risk factors for Postpartum thyroiditis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- There is insufficient evidence to recommend routine screening for PPT.
Screening
- There is insufficient evidence to recommend routine screening for PPT.
- According to the Endocrinology and Metabolism Clinics of North America[1] screening for postpartum thyroiditis by measuring anti-TPO antibodies should be limited to every high risk pregnant women with:
- Type 1 DM
- History of postpartum thyroiditis
- According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women.[2]
References
- ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.
- ↑ Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC (1988). "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction". Am J Obstet Gynecol. 159 (1): 203–9. PMID 3394739.